Ashley Webster
Physician Assistant · Asheboro, NCNPI 1871181339
Payments from drug & device makers
Across 290 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$545
- AstraZeneca$492
- Novo Nordisk$483
- Otsuka America Pharmaceutical, Inc.$402
- Lilly USA, LLC$378
- Astellas Pharma US Inc$376
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,33499%
- Education$651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $545 |
| AstraZeneca | 21 | $492 |
| Novo Nordisk | 30 | $483 |
| Otsuka America Pharmaceutical, Inc. | 20 | $402 |
| Lilly USA, LLC | 23 | $378 |
| Astellas Pharma US Inc | 21 | $376 |
| Boehringer Ingelheim | 18 | $352 |
| Lundbeck LLC | 13 | $220 |
| Corcept Therapeutics | 7 | $196 |
| Pfizer | 10 | $181 |
| GSK | 8 | $177 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $169 |
| Exact Sciences | 8 | $156 |
| Axsome Therapeutics, Inc. | 6 | $137 |
| Bayer | 7 | $117 |
| Amgen | 6 | $105 |
| Johnson & Johnson | 6 | $96 |
| Mylan Specialty L.p. | 4 | $95 |
| Sumitomo Pharma America, Inc. | 4 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Eisai Inc. | 3 | $61 |
| Merck | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Neurocrine Biosciences, Inc. | 2 | $45 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Novavax Inc | 1 | $37 |
| Biogen | 2 | $34 |
| Renalytix AI, Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Corium, LLC | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $17 |
| Organon | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,399 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 92 | $110,850 |
| OzempicSemaglutide | 75 | $90,477 |
| JardianceEmpagliflozin | 81 | $57,219 |
| MounjaroTirzepatide | 36 | $49,057 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $46,552 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 42 | $35,489 |
| EliquisApixaban | 38 | $32,983 |
| ProliaDenosumab | 18 | $31,140 |
| RybelsusSemaglutide | 23 | $29,238 |
| WegovySemaglutide | 22 | $28,858 |
| TrulicityDulaglutide | 24 | $22,576 |
| RexultiBrexpiprazole | 16 | $20,366 |
| XareltoRivaroxaban | 20 | $15,808 |
| KerendiaFinerenone | 17 | $13,549 |
| LinzessLinaclotide | 17 | $9,858 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $492 | $151,330150 claims |
| Novo NordiskOzempic, Rybelsus, Wegovy | $483 | $148,574120 claims |
| Lilly USA, LLCMounjaro, Trulicity | $378 | $71,63360 claims |
| Boehringer IngelheimJardiance | $352 | $57,21981 claims |
| GSKTrelegy Ellipta | $177 | $46,55254 claims |
| PfizerEliquis | $181 | $32,98338 claims |
| AmgenProlia | $105 | $31,14018 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $402 | $20,36616 claims |
| Johnson & JohnsonXarelto | $96 | $15,80820 claims |
| BayerKerendia | $117 | $13,54917 claims |
| AbbVieLinzess | $545 | $9,85817 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $79 | $9,72327 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Asheboro
- Frank HoustonAsheboro$30K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.